A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Clinical trial NCT05862259 · RECRUITING

Trial details

NCT number: NCT05862259
Sponsor: Xinqiao Hospital of Chongqing
Status: RECRUITING
Study type: OBSERVATIONAL

Malignant Tumor Immunotherapy Artificial Intelligence

Start date: 2023-08-10
Primary completion: 2025-08-10
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.